PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
8 hedge funds and large institutions have $2.33M invested in PureTech Health in 2025 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
33% more funds holding
Funds holding: 6 → 8 (+2)
1.31% more ownership
Funds ownership: 0.16% → 1.47% (+1.3%)
1% more capital invested
Capital invested by funds: $2.32M → $2.33M (+$12.4K)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
Top Sellers
| 1 |
BHIA
Birch Hill Investment Advisors
Boston,
Massachusetts
|
-$1.04M |
| 2 |
Millennium Management
New York
|
-$371K |
| 3 |
Morgan Stanley
New York
|
-$1.98K |
PRTC Hedge Fund Activity: Q2 2025 in Review
8 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q2 2025, worth a combined $2.33M — up 0.53% from $2.32M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PRTC positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 2 trimmed.
The largest buyer was Pentwater Capital Management, adding an estimated $289K. The largest seller was Birch Hill Investment Advisors, cutting an estimated $1.04M.
- 8 institutional investors held PureTech Health (PRTC) as of Q2 2025, up from 6 in Q1 2025.
- Funds reported $2.33M of PureTech Health stock for Q2 2025, up 0.53% quarter-over-quarter.
- 3 funds opened new PureTech Health positions in Q2 2025 and 1 closed out, a net change of +2 holders.
- The largest PureTech Health buyer in Q2 2025 was Pentwater Capital Management, an estimated $289K added.
- The largest PureTech Health seller in Q2 2025 was Birch Hill Investment Advisors, an estimated $1.04M sold.
Based on aggregated 13F filings for Q2 2025.